Todor Jeliaskov brings over 20 years of experience solving customers' needs and generating returns for investors and shareholders at large, complex enterprises and startup organizations across continents and various industries.
This funding will enable RetiSpec to accelerate the commercialization of its groundbreaking technology aimed at early detection of Alzheimer's disease.
